ArticleCell reports. Medicine2025

Inhibiting KRAS with CD47 and immune checkpoint overcomes intrinsic resistance to combined KRAS and immune checkpoint inhibitor therapy.

Kentaro Hirade et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.